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Abstract 
Purpose: To investigate the therapeutic effects of Jiaotai pill (JTP) on rats with insomnia induced by p-
chlorophenylalanine (PCPA). 
Methods: Rats with PCPA-induced insomnia were divided into 5 groups (n = 10), made up of control 
group, positive treatment group (estazolam 0.1 mg/kg), and 3 JTP treatment groups (0.6, 1.2 and 2.4 
g/kg). Another group of 10 rats were treated as normal group. Rats in normal and control groups were 
treated with normal saline (10 mL/kg). After 14 days of drug treatment, the rats were injected 
intraperitoneally with sodium pentobarbital (45 mg/kg) and thereafter, latent period and sleeping time 
were recorded, while contents of γ-aminobutyric acid (GABA) and glutamic acid (Glu) in hypothalamus 
were determined by high performance liquid chromatography (HPLC). Furthermore, the expressions of 
glutamate decarboxylase 65 (GAD-65), glutamate decarboxylase 67 (GAD-67), GABA-
aminotransferase (GABA)-T, anti-GABA transporter 1 (GAT)-1, anti-GABA transporter (GAT)-3, and 
GABA receptors (GABA-A and GABA-B) in the hypothalamus were analyzed by western blotting assay.  
Results: The results showed that JTP (0.6, 1.2 and 2.4 g/kg) significantly shortened latent period and 
prolonged sleeping time (p < 0.01). JTP also increased GABA level (p < 0.01), but decreased Glu 
contents of the rat hypothalamus (p < 0.01). Western blotting data indicate that JTP significantly up-
regulated the levels of GAD-65 (p < 0.01), GAD-67 (p < 0.05), GAT-1 (p < 0.01), GAT-3 (p < 0.01), 
GABA-A (p < 0.01) and GABA-B (p < 0.01), while the level of GABA-T was down-regulated. 
Conclusion: The results demonstrate that JTP possesses significant sedative effects on insomnia in 
rats, most probably through a mechanism involving GABA signal pathway. 
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Insomnia is one of the most common clinical 
diseases, and is also the most common sleep 
disorder [1,2]. It is reported that the occurrence 
of insomnia is often related to psychological 
depression and anxiety, negative emotions 
caused by life events or disease [3]. Results of 
epidemiological studies indicate that the 
incidence of insomnia in adolescents and the 
elderly are approximately 11 and 40 %, 
respectively [3,4]. Thus, research efforts have 
increasingly focused on the search for insomnia 
therapy. The anti-insomnia drugs currently in 
clinical use are mainly western medications, 
amongst which are benzodiazepine receptor 
agonists. However these drugs are associated 
with side-effects, dependence and tolerance over 
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time. It has been demonstrated that Chinese 
traditional medicine system has significant effect 
on insomnia, and it also has low adverse side 
effect [5]. 
 
Jiaotai pill (JTP) is a traditional Chinese 
medicinal preparation which contains two 
Chinese herbal medicines (Coptidis rhizoma and 
Cinnamomi cortex) [6]. Many studies have shown 
that JTP has the significant therapeutic effects on 
insomnia [6-8]. However, the possible 
mechanism of JTP-induced therapy of insomnia 
has not been studied clearly so far. The present 
study was designed to investigate the effects of 





Chemicals and reagents 
 
The reference standards (γ-aminobutyric acid 
and glutamic acid), p-chlorophenylalanine 
(PCPA), ortho-phthalaldehyde and sodium 
pentobarbital were obtained from Sigma-Aldrich 
(St. Louis, MO, USA). Estazolam was obtained 
from Kunming Zhenhua Pharmaceutical Co. 
(Kunming, China). The primary antibodies of 
glutamate decarboxylase (GAD)-65, GAD-67, γ-
aminobutyric acid transaminase (GABA-T), anti-
GABA transporter (GAT)-1, anti-GABA 
transporter (GAT)-3, GABA receptors (GABA-A 
and GABA-B) were purchased from Abcam Co. 
(Cambridge, MA, USA). All other chemical 





Male specific pathogen-free (SPF) rats (weighing 
180 – 220 g) were purchased from the 
Laboratory Animal Center of Fujian Medical 
University (Fuzhou, China). The animals were 
maintained under controlled conditions with 
natural lighting, and allowed free access to food 
and water. All the animal experimental protocols 
were performed in accordance with “Principles of 
Laboratory Animal Care” (NIH publication no. 85-
23, revised 1985) [9], and were approved by the 
Animal Care and Use Committee of Fujian 
University of Traditional Chinese Medicine [no. 
2016-04-05]. 
 
Animal grouping and treatment  
 
Insomnia animal model was established 
according to previously reported method with 
minor modifications [10]. Male rats were 
administrated PCPA by intraperitoneal injection 
(350 mg/kg, i.p.) once a day for 2 days. A total 50 
male insomnia rats were divided into 5 groups (n 
= 10), which consisted of model group, positive 
treated group and 3 JTP treated groups (0.6, 1.2 
and 2.4 g/kg). In addition, a group of 10 
insomnia-free rats served as normal control. Rats 
in normal and model groups were treated with 
normal saline (10 mL/kg). After 14 days of 
continuous drug/saline treatment, all the rats 
were injected i.p. with sodium pentobarbital (45 
mg/kg). Then, the sleep latency and sleep time 
were recorded, and the rats were sacrificed by 
decollation. The hypothalamus of each rat was 
carefully excised and stored at -80 °C prior to 
analysis. 
 
Determination of GABA and Glu contents of 
hypothalamus 
 
The levels of GABA and Glu in the hypothalamus 
were determined by HPLC method with pre-
column derivatization assays [7,11]. In this 
procedure,1 mL HClO4 (0.1 mol/L) was added to 
0.2 g hypothalamic tissue, and the tissue was 
then homogenized  at 4 °C and centrifuged at 
12000 rpm for 20 min at the same temperature. 
To 40 μL of the supernatant fraction was added 
40 μL of orthophthalaldehyde (OPA) solution, 
and mixed. The resultant solution was kept for 
few minutes in the dark. The OPA solution was 
prepared by mixing 10 mg OPA, 1 mL methanol, 
9 mL boric acid buffer (pH = 11, 0.04 mol/L) and 
40 μL 2-mercaptoethanol. The solution was 
filtered through a 0.22 μm filter before HPLC 
analysis. GABA and Glu standards were labeled 
in the same manner as the hypothalamic tissue 
samples.  
 
The OPA-labeled hypothalamic tissue samples 
and standards were analyzed by HPLC 
(Shimadzu, LC-2010A, Japan) with C18 column 
(4.6 mm × 250 mm, 5 μm). Solution A was 
phosphate buffer (25 mmol/L, pH 6.8) with 3 % 
acetonitrile. Solution B was phosphate buffer (25 
mmol/L, pH 6.8) with 50 % acetonitrile. The 
mobile phase was a mixture of solution A and 
solution B according to the following gradient: 0 – 
15 min, 15 % solution B; 15 – 50 min, 30 % 
solution. The flow rate and the temperature of the 
column were set to 1.0 mL/min and 30 °C, 
respectively. The wavelengths for fluorescence 
detection and excitation were set at 425 and 338 
nm, respectively. 
 
Western blotting assay 
 
The hypothalamic tissues were cut into small 
sections and treated with lysis buffer containing 
protease and phosphatase inhibitors. The 
supernatant was obtained by centrifugation at 
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12000 rpm for 15 min at 4 °C. Total protein 
concentration of the supernatant was measured 
using BCA protein assay reagent (Pierce, 
Rockford, IL, US). Then, 35 μg proteins were 
separated by 12 % SDS/PAGE, transferred to 
polyvinylidene difluoride (PVDF) membrane and 
probed with various primary antibodies (GAD-65, 
GAD-67, GABA-T, GAT-1, GAT-3, GABA-A and 
GABA-B), followed by incubation with the 
secondary antibodies. The target protein bands 
were visualized by chemiluminescence detection, 





All data are expressed as mean ± standard 
deviation (SD) and group comparison was 
performed by ANOVA (SPSS 16.0). P < 0.05 
was considered statistically significant (* and ** 





Effect of JTP on latent period and sleeping 
time  
 
The effects of JTP on sleep latency and sleep 
time of rats with insomnia are presented in 
Figures 1 and Figure 2. The results showed that 
the latent period of model rat was significantly 
longer than that of normal rat, whereas the 
sleeping time was remarkably shorter, indicating 
that the insomnia model was successfully 
established. The latent periods of rats in the 
positive treated group and 3 treated JTP groups 
(0.6, 1.2 and 2.4 g/kg) were significantly 
decreased when compared with that of model 
rats (p < 0.01). Furthermore, the sleeping time of 
JTP treated rats was significantly longer than that 
of model rats (p < 0.01). 
 
 
Figure 1: Effect of Jiaotai pill on latent period of 
insomnia rats. Data are expressed as mean ± SD (n = 
10); *p < 0.05, **p < 0.01, compared with model group 
 
Figure 2: Effect of Jiaotai pill on sleeping time of 
insomnia rats. Data are expressed as mean ± SD (n = 
10), *p < 0.05, **p < 0.01, compared with model group 
 
Contents of GABA and Glu in hypothalamus 
 
The levels of GABA and Glu in hypothalamus of 
the rats are shown in Figure 3 and Figure 4. 
GABA content of rat in model group was 
significantly lower than that of normal rat (p < 
0.01). However, Glu levels in model rats were 
significantly increased (p < 0.01). More 
importantly, after treatment with JTP (0.6, 1.2 
and 2.4 g/kg), GABA contents were significantly 
increased (p < 0.05, p < 0.01) whereas Glu levels 
were significantly decreased, when compared 
with the model rats (p < 0.01). 
 
 
Figure 3: Effect of Jiaotai pill on Glu of insomnia rats. 
Data are expressed as mean ± SD (n = 10), *p < 0.05, 
**p < 0.01, compared with model group 
 
 
Figure 4: Effect of Jiaotai pill on GABA of insomnia 
rats. Data are expressed as mean ± SD (n = 10), *p < 
0.05, **p < 0.01, compared with model group 
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Effect of Jiaotai pill on expressions of GABA 
signal-related proteins 
 
As can be seen from Figure 5, expressions of 
GAD-65, GAD-67, GAT-1, GAT-3, GABA-A and 
GABA-B were down-regulated in insomnia rats 
when compared to the normal rats (p < 0.01). 
However, JTP at dose of 2.4 g/kg significantly 
up-regulated  expressions of GAD-65 (p < 0.01), 
GAD-67 (p < 0.05), GAT-1 (p < 0.01), GAT-3 (p < 
0.01), GABA-A (p < 0.01) and GABA-B (p < 0.01) 
in hypothalamus of insomnia rats, when 
compared with untreated insomnia rats. 
Furthermore, GABA-T was up-regulated in 
insomnia rats relative to normal rats (p < 0.01), 
and the JTP (2.4 g/kg) treatment down-regulated 
GABA-T expression in insomnia rats compared 




GABA and Glu, two major neurotransmitters, 
exert effects on the excitation/inhibition balance 
in the central nervous system (CNS) [12]. GABA, 
an important non-protein amino acid, has 
inhibitory effects on CNS through blockage of 
excessive excitement of excitatory neurons [11]. 
In addition, Glu is recognized as an important 
excitatory neurotransmitter [13]. Therefore, the 
contents of GABA and Glu could be used to 
reflect the degree of insomnia. In the present 
study, JTP increased the GABA content of 
hypothalamus of insomnia rats, but decreased 
the Glu content. This indicates that JTP is a 
potential source of drug (s) for relieving 
symptoms of insomnia. 
 
 
Figure 5: Effect of Jiaotai pill on expressions of GABA signal-related proteins in insomnia rats. 1-3 represented 
the Normal, Model and JTP (2.4 g/kg), respectively. Data were expressed as mean ± SD (n = 10); *p < 0.05, **p 
< 0.01, compared with model group 
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The GABA signal pathway performs two 
functions: synthesis and transport of GABA, and 
synaptic and non-synaptic release of GABA [14]. 
The synaptic release of GABA is related to 
certain proteins such as GAD-65, GAD-67 and 
GABA-T, which are responsible for converting 
glutamate to the GABA [15,16]. The transport of 
GABA neurotransmitter is related to GABA 
transporters such as GAT-1, GAT-1, GAT-1 and 
GAT-3, which belong to the solute carrier 6 
genes family A (SLC6A) of Na+-dependent 
transporters [17].  
 
GAT regulates the GABA concentration in the 
brain and is used as new drug for the treatment 
of treating several CNS diseases [17-19]. In 
addition, GABA signal pathway is mediated by 
the two major GABA receptors (GABA-A and 
GABA-B). GABA-A receptor responds to GABA 
release by producing excitatory and inhibitory 
cellular responses. The inhibitory effects of 
GABA-B on GABA release influences circadian 
control [14]. In the present study, results of 
western blotting assay showed that JTP up-
regulated the expressions of GAD-65, GAD-67, 
GAT-1, GAT-3, GABA-A and GABA-B, whereas 




The results obtained in the present study 
demonstrate that JTP exerts sedative effects on 
PCPA-insomnia in rat. The probable mechanism 
of action is related to regulation of GABA signal 
pathway. These findings provide some scientific 
bases for the clinical use of Jiaotai pill in the 
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